Evaluation of a New Virtual Care Pathway for Older Adults With Noncommunicable Diseases

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 60 years and older
• All sexes
• No healthy volunteers
• Adult, Older adult

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Feasibility and Economic Evaluation of a Teleconsultation Care Pathway for Older Patients With Noncommunicable Diseases at an Academic Primary Care Clinic in Kuala Lumpur, Malaysia

Conditions

Hypertension (HTN), Diabetes, Dyslipidaemia

Being tested

Teleconsultation care pathway for older adults with NCDs (TeleCOOP-NCD©)

Keywords

Teleconsultation, Care Pathway, Noncommunicable diseases, Older adults, Primary care

Medical subject headings

Hypertension, Diabetes Mellitus, Dyslipidemias, Noncommunicable Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Teleconsultation care pathway for older adults with NCDs (TeleCOOP-NCD©)Other

  The intervention is the implementation of a newly designed teleconsultation care pathway for older patients with noncommunicable diseases (TeleCOOP-NCD©) at the primary care clinic of Hospital Canselor Tuanku Muhriz (KP-HCTM).

  Medical officers and Family Medicine Specialists from the KP-HCTM will provide teleconsultation to participants in the intervention arm, at 3-month and 6-month follow-up visits, according to the TeleCOOP-NCD© care pathway. Each teleconsultation may take around 30 minutes (or more, based on the individual needs of patients). There will be only two times of teleconsultations over the study period of six months for each participant under this arm. The participants can receive the teleconsultation at their homes. The appointments for the two teleconsultations will be scheduled well in advance, and they will be reminded at least one day before the appointment dates respectively.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Change from Baseline in Patient Satisfaction at 6 Months

   The original English version of the Patient Satisfaction Questionnaire Short Form (PSQ-18) or the validated Malay version (Ganasegeran K et al., 2014) will be used. The PSQ-18 includes 18 items covering 7 domains: general satisfaction (2 items), technical quality (4 items), interpersonal manners (2 items), communication (2 items), financial aspects (2 items), time spent with the doctor (2 items), and accessibility and convenience (4 items). All Items are scored on a 5-point Likert scale (minimum 1 and maximum 5). 9 items are to be reverse-scored. After that, overall satisfaction score will be calculated by averaging the scores from all items and the change from baseline in patient satisfaction at 6 months will be reported for each arm. The higher score means greater overall patient satisfaction.

   Measured: Baseline and 6 months

2. Change from Baseline in Health-related Quality of Life (HRQoL) at 6 Months

   The EQ-5D-5L questionnaire is a validated tool to measure the HRQoL. It includes two parts: the descriptive part with five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and the visual analogue scale (EQ-VAS). Each dimension has a 5-point Likert scale (1= no problems; 5= extreme problems). These responses are combined into a single multi-attribute utility index score for each participant. Then it will be converted to the respective EQ-5D index values of individual participants by using the EQ-5D-5L value set for the Malaysian Population (minimum possible utility score= -0.442 and maximum score = 1.0; higher index values representing a better health state). The EQ-VAS allows patients to rate their overall health on the day of the assessment, with the minimum score being 0 (the worst imaginable health) and the maximum score being 100 (the best imaginable health). Higher EQ-VAS scores represent better HRQoL.

   Measured: Baseline and 6 months

3. Difference in the Provider Cost between the TeleCOOP-NCD Arm and Conventional Care Arm

   The step-down costing method will be used to calculate the capital costs (for buildings and required clinic equipment which cost more than or equal to Ringgit Malaysia - RM 500) and the activity-based costing method will be used to calculate the recurrent cost incurred to operate the study site (including the costs for administration, maintenance, utilities, staff emolument and consumables). The provider cost for each arm is assessed by combing the capital costs and recurrent costs. From that, the difference in the provider cost between the two arms will be computed.

   Measured: From enrollment to the end of 6-month follow-up visit

4. Difference in the Patient Cost between the TeleCOOP-NCD Arm and the Conventional Care Arm

   The direct and indirect costs related to the clinic visit will be assessed by using the cost diary for clinic visit expenditure (filled by the participants/ their caregivers) and activity-based costing method. The patient cost will be computed by combing the direct and indirect costs related to the clinic visit from the patients' perspective.

   Measured: From the enrollment to the end of 6-month follow-up visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted25 Sep 2026
2. Study start2 Sep 2026
3. Primary completion31 Aug 2027 (estimated)
4. Study completion31 Aug 2027 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Hypertension (HTN)Studies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.